Hantz Financial Services’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Hantz Financial Services’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-500	Closed	–	–	2560
2025 Q3	$0	Buy	+500	New	–	﹤0.01%	2472
2025 Q2	–	Sell	-500	Closed	–	–	2326
2025 Q1	$0	Buy	+500	New	–	﹤0.01%	2021

Hantz Financial Services's INFI Position: Q4 2025 in Review

Hantz Financial Services sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2025, closing a stake of 500 shares.

Hantz Financial Services first reported a position in INFI in Q1 2025 and held it in 2 quarters. The position peaked at $0 in Q3 2025. 1 fund tracked by Wall St. Rank holds INFI as of Q4 2025.

Hantz Financial Services reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2025 after selling out during the quarter.
Hantz Financial Services sold 500 Infinity Pharmaceuticals, Inc. shares in Q4 2025.
Hantz Financial Services first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2025 and held it in 2 quarters.
Hantz Financial Services's Infinity Pharmaceuticals, Inc. position peaked at $0 in Q3 2025.
1 fund tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2025.

Based on Hantz Financial Services's 13F filing for Q4 2025, filed 9 Feb 2026.